Patents by Inventor Sandra Jennings

Sandra Jennings has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20180332901
    Abstract: An inventive baby swaddle is disclosed for protecting a baby's skin from harmful bacteria, chemicals, toxins, while providing the baby's skin with vitamins and minerals and other wellness properties such as anti-bacterial, anti-inflammatory, odor-reducing, combatting inflammation, infusing vitamins, infusing minerals and promoting healing, all while the swaddle remains breathable and comfortable. The improved baby swaddle includes two layers of body material that both contain seaweed fibers which provide the protection and benefits to the skin. The improved baby swaddle also includes head and neck support while still allowing the baby some movability.
    Type: Application
    Filed: May 18, 2017
    Publication date: November 22, 2018
    Inventor: Sandra Jennings
  • Publication number: 20070149564
    Abstract: The present application is directed to a new class of isoxazoles and their use as estrogen modulators.
    Type: Application
    Filed: December 19, 2006
    Publication date: June 28, 2007
    Applicant: PFIZER INC.
    Inventors: Simon Bailey, Stephen Barrett, Larry Bratton, Stephen Fakhoury, Sandra Jennings, Lorna Mitchell, Raj Raheja, Veerabahu Shanmugasundaram
  • Publication number: 20060194830
    Abstract: The present invention relates to methods for making racemic 2-(7-chloro-1,8-naphthyridin-2-yl)-3-(5-methyl-2-oxohexyl)-1-isoindolinone and (+)-2-(7-chloro-1,8-naphthyridine-2-yl)-3-(5-methyl-2-oxo-hexyl)-1-isoindolinone.
    Type: Application
    Filed: April 27, 2006
    Publication date: August 31, 2006
    Inventors: Sandra Jennings, Timothy Stuk
  • Publication number: 20050288322
    Abstract: The present invention relates to methods for making racemic 2-(7-chloro-1,8-naphthyridin-2-yl)-3-(5-methyl-2-oxohexyl)-1-isoindolinone and (+)-2-(7-chloro-1,8-naphthyridine-2-yl)-3-(5-methyl-2-oxo-hexyl)-1-isoindolinone.
    Type: Application
    Filed: August 18, 2005
    Publication date: December 29, 2005
    Applicant: Indevus Pharmaceuticals, Inc.
    Inventors: Sandra Jennings, Timothy Stuk